Fuso Pharmaceutical Industries,Ltd. (TYO:4538)

TYO:4538 Financials Overview

Financials in millions JPY. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2013	Mar 31, 2012
Revenue Revenue Growth	62,850	62,307	60,563	55,407	48,612	44,358
Revenue Growth	2.29%	2.88%	9.31%	13.98%	9.59%	-6.55%
Gross Profit Gross Profit Growth	16,115	15,996	16,533	13,840	15,316	12,194
Operating Income Operating Income Growth	3,017	2,641	4,132	1,966	3,817	481
Net Income Net Income Growth	2,191	2,011	2,780	1,377	4,871	372
Earnings Per Share EPS Growth	256.62	235.52	325.43	159.92	538.01	41.08
EPS Growth	-16.02%	-27.63%	103.50%	-70.28%	1209.63%	-67.47%

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2013	Mar 31, 2012
Cash & Investments Cash & Investments Growth	4,574	4,846	6,264	5,120	9,120	4,278
Total Debt Total Debt Growth	28,161	31,474	25,919	22,785	13,217	13,493
Net Cash (Debt) Net Cash Growth	-23,587	-26,628	-19,655	-17,665	-4,097	-9,215
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-2762.66	-3118.54	-2300.83	-2051.55	-452.52	-1017.64

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2013	Mar 31, 2012
Operating Cash Flow Operating Cash Flow Growth	-	-6,224	-	-	3,258	884
Capital Expenditures CapEx Growth	-	-1,266	-	-	-1,928	-1,206
Free Cash Flow Free Cash Flow Growth	-	-7,490	-	-	1,330	-322
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2013	Mar 31, 2012
Gross Margin	25.64%	25.67%	27.30%	24.98%	31.51%	27.49%
Operating Margin	4.80%	4.24%	6.82%	3.55%	7.85%	1.08%
Pretax Margin	4.30%	3.91%	6.23%	3.19%	12.83%	0.02%
Profit Margin	3.49%	3.23%	4.59%	2.48%	10.02%	0.84%
FCF Margin	-	-12.02%	-	-	2.74%	-0.73%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2013	FY 2012
Period Ending	Sep 14, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2013	Mar 31, 2012
Dividend Per Share Dividend Per Share Growth	90.000	90.000	82.000	70.000	60.000	60.000
Dividend Per Share Growth	3.45%	9.76%	17.14%	16.67%	0%	0%
Dividend Yield	3.99%	3.81%	3.49%	3.42%	2.11%	3.91%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2013	FY 2012
Period Ending	Sep 14, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2013	Mar 31, 2012
PE Ratio	8.55	10.03	7.43	13.53	7.71	55.74
Forward PE	-	39.53	39.53	39.53	-	-
P/FCF Ratio	-	-	-	-	28.25	-
PS Ratio	0.30	0.32	0.34	0.34	0.77	0.47

Data Source: S&P Global Market Intelligence Last updated: Aug 10, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 11, 2026

Data Sources Report a data error